HeartBeam Announces Public Offering to Fund Cardiac Technology Commercialization and AI Development

HeartBeam, a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock equivalents. The company stated that all securities will be offered by the company, with the final size and terms subject to market conditions. According to the announcement, Titan Partners, a division of American Capital Partners, will act as sole bookrunner for the offering.

The company intends to use net proceeds from the offering to advance commercialization of its FDA-cleared 12-lead synthesized ECG system. This technology represents a significant advancement in cardiac monitoring, as it creates the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing the signals into a 12-lead ECG. The platform is designed for portable devices that can be used wherever the patient is located to deliver actionable heart intelligence to physicians.

Additional funding will support further development of the company's extended-wear patch and heart attack detection initiatives. The company also plans to enhance its AI capabilities and support working capital and general corporate purposes. HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, and the 12-lead ECG synthesis software received clearance in December 2025. The company holds over 20 issued patents related to technology enablement.

The offering announcement comes as HeartBeam seeks to transform the detection and monitoring of critical cardiac conditions. The company's technology enables physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of traditional medical facilities. This approach has the potential to redefine the future of cardiac health management by making sophisticated monitoring more accessible and portable.

Investors can find additional information about the company and its developments through various channels. The latest news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT. The company's forward-looking statements are subject to numerous risks and uncertainties, including those detailed in its SEC filings. These statements involve factors that may cause actual results to differ materially from expressed expectations. The full press release containing the offering announcement can be viewed at https://ibn.fm/pxFOz. All parties undertake no duty to update this information unless required by law, and full terms of use and disclaimers applicable to all content are available at http://IBN.fm/Disclaimer.